chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was given Prevnar-20 vaccine outside of CDC guidelines. Patient had completed series of Pneumonia vaccinations with PPSV23 in 2013 and PCV13 in 2015. Patient only had soreness at the injection site for 1-2 days. There were no major/severe side effects observed per patient. Patient was notified upon the discovery of the error.
One week after vaccine my right arm got red, noticed a small knot  under my injection site, arm was warm to touch and itching.  Am assuming, since it wasn't an immediate reaction, it was "covid arm".  Today (Feb. 15) redness in arm is still visible but diminishing - still some itchiness but not all the time.  Taking benedryl as needed.
Initial information received on 27-Nov-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 72 years old female patient who experienced diarrhea and got sick, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported. On an unknown date, the patient developed a non-serious diarrhea (diarrhoea) Unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious got sick (malaise) Unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE. No lab data was reported. Final diagnosis was got sick and diarrhea. It was not reported if the patient received any corrective treatment. The patient outcome is reported as Unknown for diarrhea and as Unknown for got sick. List of documents held by sender: none.
Patient received IZs on 3/5/10. On 3/6/10 12 site became red, warm, indurated and painful. The next morning not improved and parent took to ED. We saw patient on 3/8/10-still erythemic indurated and warm.
Started rash on hands approximately 2 weeks after 1st dose. Two weeks after 2nd dose my rms, back, chest and stomach has had a rash. Sometimes itchy. Going to dermatologist and using topical steroid and 2 Zyrtec a day. Now have low platelet coming and auto pal antibodies. Having multiple blood tests to determine cause.
Pediatric patient was given 0.3 mL of COVID vaccine from Adult/teen formulation. Patient was monitored for 15 minutes with no allergic reactions noted. Accident was discovered 1 hour after vaccine given. Family has been notified. He is currently being monitored for symptoms.
Patient was given a 3rd dose of Shingrix.. Patient return to Clinic three days after injection complaining of reaction. SHe had a 3-4 inch raised area over her deltoid muscle region. Did complain of pain at the injection site.
Taken to ER  with Grand mal seizures & possible stroke; admitted to hospital with seizures
This case was reported by a consumer via call center representative and described the occurrence of headache in a 60-year-old female patient who received SHINGRIX. Co-suspect products included DTPa vaccine. On 14th March 2018 09:00, the patient received the 1st dose of SHINGRIX. On 14th March 2018, the patient received the 1st dose of dTpa vaccine. On 14th March 2018 08:00, 11 hrs after receiving SHINGRIX and less than a day after receiving dTpa vaccine, the patient experienced headache, sweating, muscle pain, fever, shivering and weakness. The patient was treated with BENADRYL, TYLNEOL and SINUTAB. On an unknown date, the outcome of the headache, sweating, muscle pain, fever, shivering and weakness were not recovered/not resolved. The reporter considered the headache, sweating, muscle pain, fever, shivering and weakness to be related to SHINGRIX. It was unknown if the reporter considered the headache, sweating, muscle pain, fever, shivering and weakness to be related to dTpa vaccine. Additional details were provided as follows: Sibling reported that her sister received SHINGRIX vaccine around 9:00 am and at 8:00 pm in the evening of vaccination day she experienced all the events. She explained that her head was killing her. The patient also had a TDAP vaccination on the same day but the vaccine was something that she had received many times since she gets the vaccine every 10 years. She took a SINUTAB around 10:00 pm in the evening of vaccination day and BENADRYL around 4:00 am and two TYLENOL between 8:00 to 9:00 am in the next morning. There had been no improvement in the side effects. On the day of reporting, she explained that her side effects were worse.
leg pain above left leg. Looks like nerve pain that randomly spreads to the right leg, back, arms, groin, inner thigh. Sometimes headaches, feeling tired and unwell
About 10 days after second shot I developed a heart arrhythmia.  I could feel it and reported it to my PCP who advised a visit to a cardiologist.  I made an appointment and was confirmed as having excessive PVCs.
got her first dose yesterday on her left arm and after that stated she felt hurt on the left arm; felt like vomiting; This is a spontaneous report from a non-contactable consumer via the Pfizer-sponsored program. A 69-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her left arm, via an unspecified route of administration on 18Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  It was reported that the patient got her first dose yesterday on her left arm and after that stated she felt hurt on the left arm and felt like vomiting. It was reported that she took 2 tabs of Tylenol that were 500mg each. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
Woke up the next morning with a neck ache. It got worse as the day went on. Around 11:00 a.m. I developed a headache. Later in the day I had chills for about 3 hours. When I woke up the next morning my neck ache and chills were gone but I had a mild headache.
Chills, fever, body aches x 24 hours - pt. was taking ibuprofen.
Pt recd vax on 6OCT92 & following vax pt devel diarrhea; No further details were provided;
The day after the vaccine my left arm got red, swollen and hot which lasted about five days. I called my after 24 hrs. They advised me to take Benadryl and ice.
Two days after vaccine in left arm, left wrist became painful, swollen, hot to the touch, burning, 4th and 5th fingers numb and tingly.  I took Prednisone and Naprosyn, wore wrist splint with no relief.  I then saw my Rheumatologist on April 12, 2021 at 7:45 a.m.  By that time, it finally started to improve so it was decided to let it run its course without further treatment with instruction if no improvement or symptoms worsen, to return for re-exam.
Pfizer 4/1/21, 4/22/21; Positive on 2/7/22
On 4/25/21 he began experiencing congestion, sore throat, fevers, loss of taste and smell. He recently returned from travelling and tested negative for COVID on 4/23/21.
Patient noticed a red line going from injection site down to the elbow. Over the course of 2 days it turned into a very large erythemous area from the shoulder to the elbow and around the arm. Checked area on 1/28 still red down to the elbow.
This spontaneous report as received from a nurse refers to a 46 year old female patient. Pertinent medical history, concomitant medication, drug reactions and allergies were not provided. The nurse stated that the patient was incorrectly vaccinated today (on 07-MAY-2014). The nurse stated that she reconstituted the M-M-R II (lot # 1505AA, batch #H018945; expiration date 21-MAR-2015, also reported as 18-OCT-2014) and the MENVEO and then mixed them together in the same syringe and administered it to the patient, in her left arm (route of administration was not reported). No adverse effects were reported. No Product Quality Complaint (PQC) was involved. Additional information is not expected.
eye condition; pain in eye; eye swollen; Drug dose administration interval too long; This case was reported by a consumer via call center representative and described the occurrence of eye disorder in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (estimated date for the 1st shot was over 6 months before the reporting date).   On 9th May 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 9th May 2019, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced eye disorder, eye pain and eye swelling. The patient was treated with ophthalmologicals (Eye Ointment (Ingredients Or Trade Name Unknown)). On an unknown date, the outcome of the eye disorder, eye pain and eye swelling were recovering/resolving and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the eye disorder, eye pain and eye swelling to be related to Shingrix.  Additional details were reported as follows: On 9th May 2019, the patient received the 2nd dose of Shingrix, which led to lengthening of the vaccination schedule. A couple of days later, the patient felt as if she had a stye in one of her eyes.   The doctor stated it was not a stye and gave her some ointment to apply.   It was painful and swollen but improved with the use of the ointment however, it is now in the other eye. Two days after vaccination, the patient experienced eye disorder, eye pain and eye swelling. The reporter did not give consent to follow up. The emergency visit required.
pt recvd vax 3MAY03 & 10MAY93 pt devel elevated BP & a rash resembling chicken pos; No further details were provided;
provider did not initially think that dose was invalid; This non-serious case was reported by a nurse via sales rep and described the occurrence of expired vaccine used in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) (expiry date 30-APR-2023) for prophylaxis.   On 06-JUN-2023, the patient received Menveo (unknown arm). On 06-JUN-2023, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: provider did not initially think that dose was invalid). The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 8-Jun-2023 The reporter stated that the clinic enforced a process for a second verifier of vaccines but the second check did not happen in this case.  The reporter stated that provider did not initially think that dose was invalid and that the patient did not need to receive a second dose. The reporter did not know the dose of the vaccine. The reporter did not consent to follow-up. The patient received an expired dose of Menveo, which led to expired vaccine used.
Pt experienced anaphylaxis with 1st dose of Pfizer cov19 vaccine, but patient wanted to be fully vaccinated due to losing a family member to Cov19. Patient was instructed by her Md to get the Janssen vaccine instead of the 2nd dose of Pfizer vaccine that was due on 3/28. A few minutes after the injection, the patient became itchy and had increased respiratory rate. Despite using her inhaler and receiving a dose of liquid Benadryl, the patients breathing worsened, and I injected the patient with an Epipen. Patients breathing improved and we monitored her for an hour before releasing her. A follow-up call was made on 4/13 to confirm the patient was stable.
Within 5 seconds post vax, pts eyes rolled back, body limp, unresponsive. Pt was moved to floor - head shaking, arms drawn up to chest and right hand clenched. Pt came to in 20 - 30 seconds. Speech was slurred BP 86/56. 12 noon BP 90/60; feel fine. Pt had just eaten crackers and grape juice.
pt recv vax 8OCT97  & by 11OCT97 pt had fever & swollen arm;by 15OCT97 the site of 1mm was twice as big & red;now it is moving down the arm & it still hurts;
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received SHINGRIX for prophylaxis. On 28th March 2019, the patient received the 1st dose of SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced pain in arm, general body pain, weakness, tiredness, headache, upper abdominal discomfort and upper abdominal pain. On an unknown date, the outcome of the pain in arm, general body pain, weakness, tiredness, headache, upper abdominal discomfort and upper abdominal pain were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, general body pain, weakness, tiredness, headache, upper abdominal discomfort and upper abdominal pain to be related to SHINGRIX. Additional case details were provided as follows: The age at vaccination was not reported. The patient received the dose of SHINGRIX vaccine on the day before the reporting in the arm and experienced side effect such as whole arm hurts, body aches, tired-weak, headache. The patient wanted to know how long the symptoms would last. The patient requested to send the ingredients to this SHINGRIX shot. The patient gave consent to follow up.
Slight tingling sensation of the extremity of vaccine administration. Monitored for 30 minutes. stable.
Severe fever (103), nausea/vomiting and debilitating myalgias/arthralgia. Symptoms are lessening with 800mg ibuprofen, TID, but persistent.
Patient called our pharmacy on 7/1/2022 and talked to pharmacist on duty.  She said that she was diagnosed with Guillian-Barre Syndrome and her physician said it was caused from the shingles vaccine she received on 5-7-22.
Patient had ALTE with 2 apneic events  reqiring rescue intervention by parent.  Patient transferred to our facility for further management.  Patient discharged with home apnea monitor. 12/10/08-records received for DOS 6/7-6/10/08-Presented with 2 episodes of apnea, turned dusky stopped breathing and received mouth to mouth rescue breathing.
Severe pain in chest. Heavy/hard heartbeat. Severe pain down left arm. It started on the evening of the second day and persisted throughout the night into morning. I went to work the next day and a tightness remained in my chest until the evening. I did not go to a doctor although I felt I needed to. I chewed two 80 mg aspirins approximately at 2 AM the night the pain started. I also chewed 2 more 80 mg aspirins approximately at 8 AM when I arrived at work. They seemed to help the pounding in my chest but not the pain really. I did this as I read it might be beneficial to chew aspirin when you have heart attack symptoms, which I thought I was having as I never had pain in my chest like that. I am reporting this now as I recently learned of VAERS.
Positive COVID breakthrough 3 months after 4th vaccine.  Treatment course:  Paxlovid, LevoFLOXacin, Prednisone, Albuterol nebulizer, Benzonatate
Grand mal seizure causing multiple bruises. Dr did catscan and blood work and put patient on Dilantin for the short term.
The shot was given higher than most I've ever received - pretty much in my very upper arm/shoulder. Immediately I felt a pain shoot down the inside area of my arm to my wrist, near my thumb. The pain continued, and worsened, over the next few weeks. I visited an orthopedic office, where they took x-rays. The pain had gotten all but unbearable, after self-treatment with various OTC pain relievers, salon pas pain patches, rest, heat, ice. I was diagnosed with De Quervain's tenosynovitis, continued the same treatment with the addition of a brace (palm of hand to elbow) to limit wrist movement and meloxicam. It still hurts, which impedes the use of my right arm, which I need for my job. It even hurts to do something as simple as brushing my teeth.
All over body muscle aches (shoulders, neck, arms, back, hip flexors) and feeling feverish, nauseated and fatigued, for just over 24 hours from when I received the vaccination.
Same night of vaccination on 12/21/2020 I felt a little pain on my shoulder and a little fever of 100 degrees & on 12/25/2020 I started feeling sick I started with a runny nose & I had a little fever as well. On Monday 12/28/2020 I went to go get tested for Covid & it came out positive & Type B flue.
pt recv vax 08MAY95 & 10MAY95 pt devel a chicken pox like rash consisting of greater than 300 lesions; MD expressed a concern w/particular lot @ of vax; f/u fr pt indicated exp full blown chickenpox on 12MAY95
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterated that because her facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment at that time. It was reported that no adverse reactions were reported by any patient. Reporter confirmed that patients had administered doses while the temperature excursion assessment was ongoing.   This case was linked to MOD-2022-501575 (Patient Link).
Information has been received from a nurse (at the physician's office) concerning a patient who was vaccinated with ZOSTAVAX (Merck). The patient experienced a case of shingles after vaccination. The outcome of the patient's shingles was not reported. Additional information has been requested.
Soreness- 2 days at onset Redness and swelling at injection site started on day 8. Still have on day 9.
This spontaneous report as received from a pharmacist refers to a 57 years old female patient who on 15-SEP-2012 was vaccinated with single 0.65 ml dose of ZOSTAVAX subcutaneously (lot number not reported). No other co-suspects were reported. Concomitant medications included estradiol and timolol (manufacturer unknown). The pharmacist reported that the patient came back into the pharmacy on 18-SEP-2012 with a red area about the size of a quarter with warmth at the immediate injection site and a larger red area about 4 or 5 inches in diameter around the smaller red area. The patient experienced the adverse events several days after the injection. The patient took aspirin and the pharmacist suggested TYLENOL for the treatment of adverse events. The patient's outcome for the adverse event was not reported. The relatedness for the adverse events was unknown for ZOSTAVAX. Additional information has been requested.
I got a blood clot, venous, in my upper right leg.   Started on or about March 3rd, 2021
Patient was given Hep A Ped/ADOL Dose. Patient notified and per CDC info will return to receive Hep A adult dosage. No adverse events reported by patient.
No additional AE's; temperature excursion that occurred on PROQUAD were administered.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, pertinent medical history, concomitant therapies and drug and/or allergies reactions was not provided.   On 16-JUL-2021, the patient was inadvertently administered with improperly stored  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose, vaccination scheme, route and anatomical location of administration were not provided, with lot number T019422 verified as valid and upon internal review expiration date established as 02-DEC-2021) for prophylaxis.  Measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was improperly stored at a temperature of 15.6 degrees Fahrenheit of a reported range from minus 58 degrees Fahrenheit to 5 degrees Fahrenheit for a time frame 32 minutes. Another temperature excursion was called at a temperature of 8.4 degrees Fahrenheit for a time frame of 9 minutes. It was reported previous temperature excursion of 15.6 degrees Fahrenheit, and this was called because of a data logger. No additional adverse event was reported   This is one of two reports received from the same reporter.
Patient reaction started at 2200 12/05/2019. Right arm redness and swelling, difficulty moving arm. Provider examined patient in office on 12/06/2019. Provider prescribed cephalexin 250 mg/5mL to treat cellulitis. Patient is to take antibiotic as prescribed. Provider explained to parent that Benadryl and icing may help with local reaction.
Still a red hard spot at 1st vaccine arm spot 10 days later. No pain, only red, hard and itching at times.
This case was reported by a consumer and described the occurrence of viral illness in an adult female subject who was vaccinated with influenza virus vaccine (Fluarix) for prophylaxis. The reporter is the subject. A physician or other health care professional has not verified this report. On 02 November 2005 the subject received a dose of Fluarix. The subject did not provide information regarding previous immunization with influenza virus vaccine. On an unspecified date on or before 08 November 2005, within days of vaccination with Fluarix, the subject experienced tiredness On 06 November 2005, she experienced swollen glands and difficulty swallowing. On an unspecified date on or before 08 November 2005, the subject was seen at a physician's office. The subject reported that the physician told that she had, "a non-specific viral illness." The swollen glands and difficulty swallowing resolved on or after 06 November 2005 and on or before 08 November 2005. The viral illness and tiredness were ongoing at the time of initial reporting, 08 November 2005. Follow-up will not be available.
Patient reported he was due for second moderna dose.  Second dose was given and found to be only 19 days after the initial dose.  No side effects noted at time of administration
Loose stools, fever approx. 101 degrees, headache, lethargic/very tired, uncomfortable stomach pain.  Loss of appetite.
Fatigue, fever, headache, body aches, swollen lymph nodes under right arm.